Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib

BACKGROUND: Although with the impressive efficacy, several patients showed intrinsic resistance or an unsatisfactory response to Osimertinib. We aim to explore the impact of clinical and molecular features on efficacy and outcome of patients with EGFR T790M-mutation non-small cell lung cancer (NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ying, Lin, Chen, Shi, Xun, He, Qiong, Yan, Junrong, Yu, Xinmin, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145492/
https://www.ncbi.nlm.nih.gov/pubmed/35643428
http://dx.doi.org/10.1186/s12885-022-09683-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145492/
https://www.ncbi.nlm.nih.gov/pubmed/35643428
http://dx.doi.org/10.1186/s12885-022-09683-1

Ejemplares similares